Filter
561 - 570 of 1287 results
Results for
Studying National Trends in Homelessness
Project
To successfully address homelessness in the U.S., we need to understand the extent of the challenge at local, state levels.
Spotlight On: Disability Policy & Research
Spotlight On
Abt helps clients improve their policies and programs with objective research and implementation support in the areas of employment, income supports, education, housing and health.
Participants in Training Program Gain Skills, Higher Wages and Healthcare Jobs
Publication
The Conrad N. Hilton Foundation's Youth Substance Use Prevention and Early Intervention Strategic Initiative
Publication
Behind HRSA’s Global HIV/AIDS Coordination
Impact Brief
HRSA program provides versatile TA for vast portfolio of HIV/AIDS Programs, furthers bidirectional US-Global learning agenda and local system strengthening for HIV services
Rooted in Results: Powering Conservation Technology for America's Farmers and Ranchers
Impact Brief
Abt delivers streamlined technology systems that enable NRCS to provide timely conservation funding and support when farmers need it most.
Spotlight On: Protecting Children and Promoting Healthy Families
Spotlight On
Reducing infant mortality. Supporting child welfare agencies. Preventing abuse and neglect. Abt’s work helps support the backbone of policies and programs that protect those who are most vulnerable.
Spotlight On: PFAS, Environmental Contamination, and Health
Spotlight On
Abt has extensive experience investigating and addressing the complex effects of per- and polyfluoroalkyl substances (PFAS) in the environment and on human health.
Australasian AID Conference 2026
Event
Abt Global is excited to be presenting at the Australasian AID conference again in 2026. Learn about our panels and how to connect with us at AAC2026.
How Can We Eradicate Infectious Diseases Using Machine Learning?
Podcast
In this month’s episode, Abt experts Jill Berkowitz and Sung-Woo Cho discuss how machine learning can amplify our work combatting malaria—25 million people protected to date—by applying what we’ve learned to other infectious diseases.